Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.

Autores de IIS La Fe

• Manuel De Juan Burgueño

  Autor

• Guillermo Bastida Paz

  Autor

• Joaquin Ernesto Hinojosa De Val

  Autor

Participantes ajenos a IIS La Fe

• Chaparro M
• Iglesias E
• Panés J
• Muñoz F
• Castro L
• Jiménez C
• Mendoza JL
• Barreiro-de Acosta M
• Senent SG
• Gomollón F
• Calvet X
• García-Planella E
• Gómez M
• Hernández V
• Mañosa M
• Nyssen OP
• Gisbert JP

Grupos

• Enfermedad Inflamatoria Intestinal

Abstract

Ciclosporin has proven to be effective in patients with corticosteroid-refractory ulcerative colitis (UC). When therapy with this drug fails, infliximab can be considered to avoid colectomy. The efficacy and safety of this sequential approach remain unknown.